Pet Anthelmintic Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Pet Anthelmintic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
External
Internal
Composite
Injection
Segment by Application
Dog
Cat
Others
By Company
Elanco
Boehringer Ingelheim
Ceva Sante Animale
Chanelle Group
Dechra
Durvet
First Priority
Jeffers
Manna Pro Products
Merck Animal Health
Ourofino
TTK Healthcare
Vetoquinol
Virbac
Zoetis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
